178 related articles for article (PubMed ID: 11697829)
1. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumours (NSGCT).
Ann Oncol; 2001 Sep; 12(9):1215-6. PubMed ID: 11697829
[No Abstract] [Full Text] [Related]
2. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumors (NSGCT).
Huddart RA; Purkalne G;
Ann Oncol; 2005; 16 Suppl 1():i37-9. PubMed ID: 15888747
[No Abstract] [Full Text] [Related]
3. [Management of localized germ-cell tumours of the testis].
Loriot Y; Fizazi K
Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
[TBL] [Abstract][Full Text] [Related]
4. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
; Huddart RA
Ann Oncol; 2007 Apr; 18 Suppl 2():ii42-3. PubMed ID: 17491041
[No Abstract] [Full Text] [Related]
5. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
Chanal E; Bouleftour W; Guillot A; Rowinski E; Bernichon E; Tremeau L; Lardon R; Lacroix B; Lorin S; Delorme G; Perraud Y; Armand C; Levigne F; Vallard A; Langrand-Escure J; Fournel P; Benoite M; Vassal C
Bull Cancer; 2019 Dec; 106(12):1086-1093. PubMed ID: 31582176
[TBL] [Abstract][Full Text] [Related]
6. Decision analysis defining optimal management of clinical stage 1 high-risk nonseminomatous germ cell testicular cancer with lymphovascular invasion.
Avulova S; Allen C; Morgans A; Moses KA
Urol Oncol; 2018 Jul; 36(7):342.e1-342.e6. PubMed ID: 29754945
[TBL] [Abstract][Full Text] [Related]
7. Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
McKendrick JJ; Mead GM; Cowlishaw D
Clin Oncol (R Coll Radiol); 2003 May; 15(3):128-31. PubMed ID: 12801050
[No Abstract] [Full Text] [Related]
8. Cancer of the testis: a new paradigm.
Einhorn LH
Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
[No Abstract] [Full Text] [Related]
9. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Huddart R; Kataja V;
Ann Oncol; 2008 May; 19 Suppl 2():ii52-4. PubMed ID: 18456768
[No Abstract] [Full Text] [Related]
10. The management of non-seminomatous germ cell tumours (GCT).
Paz-Ares L; Lianes P; Cortes-Funes H
Ann Oncol; 1994 May; 5(5):457-62. PubMed ID: 7521207
[No Abstract] [Full Text] [Related]
11. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
12. Management of stage I testicular germ cell tumours.
Chovanec M; Hanna N; Cary KC; Einhorn L; Albany C
Nat Rev Urol; 2016 Nov; 13(11):663-673. PubMed ID: 27618772
[TBL] [Abstract][Full Text] [Related]
13. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
14. [Case of a testicular germ cell tumor presenting with multiple metastasized pulmonary nodules and masses].
Nakayama M; Saito T; Bando M; Kondo Y; Kawai K; Sugiyama Y; Akaza H; Itoh K
Nihon Kokyuki Gakkai Zasshi; 2010 Dec; 48(12):976-9. PubMed ID: 21226308
[TBL] [Abstract][Full Text] [Related]
15. Sexual Function in a Nationwide Cohort of 2,260 Survivors of Testicular Cancer after 17 Years of Followup.
Bandak M; Lauritsen J; Johansen C; Kreiberg M; Skøtt JW; Agerbaek M; Holm NV; Daugaard G
J Urol; 2018 Oct; 200(4):794-800. PubMed ID: 29730199
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy for metastatic germ cell tumours of the testis].
Culine S
Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
[TBL] [Abstract][Full Text] [Related]
18. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
Heidenreich A; Paffenholz P; Nestler T; Pfister D
Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
20. Vox populi: Using community-based studies to determine best management of early-stage nonseminoma.
Nichols CR; Kollmannsberger C
J Clin Oncol; 2009 May; 27(13):2114-6. PubMed ID: 19307494
[No Abstract] [Full Text] [Related]
[Next] [New Search]